|
Market Closed -
Nasdaq
21:00:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 22.79 USD | +1.15% |
|
-10.80% | - |
| 09-02 | Attovia Therapeutics Q2 Net Loss Widens | MT |
| 09-02 | Attovia Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Evolution of the Average Target: Attovia Therapeutics, Inc.
Evolution of the Target Price: Attovia Therapeutics, Inc.
Changes in Analyst Recommendations: Attovia Therapeutics, Inc.
81ce.Y4D1WCRQGjevEZe8eMsDJPgoGAC7KS8hDhOnXSc5O2I.MvO2M00cbHLAVuffAJIzEYlRYmPPZxZDZmbAJEYLCxgR-cAvUztwXJZ1rw~033db840e11a7f187328484d3c102f79
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +85.17% | |||
| +23.69% | |||||
| +18.14% | |||||
| +54.69% | |||||
| +23.66% | |||||
| +23.2% | |||||
| +17.29% | |||||
| +9.16% | |||||
| +32.94% | |||||
| -4.33% | |||||
| Average | +28.36% | |||||
| Weighted average by Cap. | +23.53% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
22.79USD
Average target price
42.20USD
Spread / Average Target
+85.17%
High Price Target
52.00USD
Spread / Highest target
+128.17%
Low Price Target
30.00USD
Spread / Lowest Target
+31.64%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ATTO Stock
- Consensus Attovia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
